{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:07:56Z","timestamp":1789992476969,"version":"4.0.1"},"reference-count":96,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.urolonc.2006.10.001","type":"journal-article","created":{"date-parts":[[2007,5,6]],"date-time":"2007-05-06T17:41:57Z","timestamp":1178473317000},"page":"250-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Genetic variability in inflammation pathways and prostate cancer risk"],"prefix":"10.1016","volume":"25","author":[{"given":"Jielin","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aubrey","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Gr\u00f6nberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2006.10.001_bib1","series-title":"Prostate cancer, biology, genetics, and the new therapeutics","first-page":"13","article-title":"Hereditary prostate cancer","author":"Isaacs","year":"2001"},{"key":"10.1016\/j.urolonc.2006.10.001_bib2","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/S0022-5347(17)32452-7","article-title":"Studies of genetic factors in prostate cancer in a twin population","volume":"152","author":"Gronberg","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2006.10.001_bib3","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/(SICI)1097-0045(19971201)33:4<240::AID-PROS3>3.0.CO;2-L","article-title":"Heredity and prostate cancer: A study of World War II veteran twins","volume":"33","author":"Page","year":"1997","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2006.10.001_bib4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJM200007133430201","article-title":"Environmental and heritable factors in the causation of cancer\u2013Analyses of cohorts of twins from Sweden, Denmark, and Finland","volume":"343","author":"Lichtenstein","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2006.10.001_bib5","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1073\/pnas.89.8.3367","article-title":"Mendelian inheritance of familial prostate cancer","volume":"89","author":"Carter","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.urolonc.2006.10.001_bib6","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/oxfordjournals.aje.a009313","article-title":"Segregation analysis of prostate cancer in Sweden: Support for dominant inheritance","volume":"146","author":"Gronberg","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.urolonc.2006.10.001_bib7","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1086\/301862","article-title":"Evidence for autosomal dominant inheritance of prostate cancer","volume":"62","author":"Schaid","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.urolonc.2006.10.001_bib8","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1086\/320114","article-title":"Segregation analyses of 1,476 population-based Australian families affected by prostate cancer","volume":"68","author":"Cui","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.urolonc.2006.10.001_bib9","doi-asserted-by":"crossref","first-page":"R103","DOI":"10.1093\/hmg\/ddh072","article-title":"The complex genetic epidemiology of prostate cancer","volume":"13","author":"Schaid","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.urolonc.2006.10.001_bib10","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: Back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.urolonc.2006.10.001_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1023\/A:1020110718701","article-title":"The diet, prostate inflammation, and the development of prostate cancer","volume":"21","author":"Nelson","year":"2002","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.urolonc.2006.10.001_bib12","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1056\/NEJMra021562","article-title":"Prostate cancer","volume":"349","author":"Nelson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2006.10.001_bib13","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2006.10.001_bib14","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1126\/science.274.5291.1371","article-title":"Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search","volume":"274","author":"Smith","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.urolonc.2006.10.001_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng823","article-title":"Germline mutations in the ribonuclease L gene in families showing linkage with HPC1","volume":"30","author":"Carpten","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.urolonc.2006.10.001_bib16","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1021\/bi027147i","article-title":"Implications for RNase L in prostate cancer biology","volume":"42","author":"Silverman","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.urolonc.2006.10.001_bib17","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1002\/j.1460-2075.1993.tb05999.x","article-title":"A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon","volume":"12","author":"Hassel","year":"1993","journal-title":"EMBO J"},{"key":"10.1016\/j.urolonc.2006.10.001_bib18","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1086\/340450","article-title":"Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer","volume":"70","author":"Rokman","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.urolonc.2006.10.001_bib19","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1086\/341281","article-title":"Analysis of the RNASEL gene in familial and sporadic prostate cancer","volume":"71","author":"Wang","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.urolonc.2006.10.001_bib20","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/sj.bjc.6601075","article-title":"Role of genetic polymorphisms of the RNASEL gene on familial prostate cancer risk in a Japanese population","volume":"89","author":"Nakazato","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2006.10.001_bib21","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/ng1021","article-title":"RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases","volume":"32","author":"Casey","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.urolonc.2006.10.001_bib22","first-page":"6795","article-title":"Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2\u2032,5\u2032-oligoadenylates","volume":"63","author":"Xiang","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2006.10.001_bib23","doi-asserted-by":"crossref","first-page":"7150","DOI":"10.1158\/1078-0432.CCR-04-0982","article-title":"Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer","volume":"10","author":"Wiklund","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2006.10.001_bib24","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/sj.bjc.6602401","article-title":"Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene","volume":"92","author":"Maier","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2006.10.001_bib25","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1158\/1055-9965.EPI-04-0637","article-title":"Association of susceptibility alleles in ELAC2\/HPC2, RNASEL\/HPC1, and MSR1 with prostate cancer severity in European American and African American men","volume":"14","author":"Rennert","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2006.10.001_bib26","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1086\/342775","article-title":"A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews","volume":"71","author":"Rennert","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.urolonc.2006.10.001_bib27","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1136\/jmg.40.3.e22","article-title":"The RNASEL 471delAAAG allele and prostate cancer in Ashkenazi Jewish men","volume":"40","author":"Kotar","year":"2003","journal-title":"J Med Genet"},{"key":"10.1016\/j.urolonc.2006.10.001_bib28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ng994","article-title":"Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk","volume":"32","author":"Xu","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.urolonc.2006.10.001_bib29","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI200113903","article-title":"Is the class A macrophage scavenger receptor (SR-A) multifunctional? \u2013The mouse\u2019s tale","volume":"1085","author":"Platt","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.urolonc.2006.10.001_bib30","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1086\/345802","article-title":"Common sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk","volume":"721","author":"Xu","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.urolonc.2006.10.001_bib31","first-page":"3486","article-title":"Germ-line mutations of the macrophage scavenger receptor 1 gene: Association with prostate cancer risk in African-American men","volume":"63","author":"Miller","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2006.10.001_bib32","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/ng1239","article-title":"No association of germline alteration of MSR1 with prostate cancer risk","volume":"35","author":"Wang","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.urolonc.2006.10.001_bib33","first-page":"5252","article-title":"Germ-line alterations in MSR1 gene and prostate cancer risk","volume":"9","author":"Seppala","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2006.10.001_bib34","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1158\/1055-9965.EPI-04-0202","article-title":"Macrophage scavenger receptor 1 999C>T (R293X) mutation and risk of prostate cancer","volume":"142","author":"Hope","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2006.10.001_bib35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/pros.10367","article-title":"Analysis of the macrophage scavenger receptor 1 gene in Swedish hereditary and sporadic prostate cancer","volume":"59","author":"Lindmark","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2006.10.001_bib36","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/pros.20396","article-title":"Meta-analysis of association of rare mutations and common sequence variants in the MSR1 gene and prostate cancer risk","volume":"66","author":"Sun","year":"2006","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2006.10.001_bib37","first-page":"1156","article-title":"Toll-like receptors and their role in innate immunity","volume":"85","author":"Singh","year":"2003","journal-title":"Curr Sci"},{"key":"10.1016\/j.urolonc.2006.10.001_bib38","first-page":"81","article-title":"Toll-like receptors and their ligands","volume":"270","author":"Barton","year":"2002","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.urolonc.2006.10.001_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-2427(02)00228-3","article-title":"TOLL-like receptors linking innate and adaptive immune response","volume":"91","author":"Werling","year":"2003","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.urolonc.2006.10.001_bib40","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1128\/IAI.69.3.1477-1482.2001","article-title":"Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages","volume":"69","author":"Hirschfeld","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.urolonc.2006.10.001_bib41","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1002\/1521-4141(200111)31:11<3131::AID-IMMU3131>3.0.CO;2-G","article-title":"Human toll-like receptor 2 mediates induction of the antimicrobial peptide human beta-defensin 2 in response to bacterial lipoprotein","volume":"31","author":"Birchler","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.urolonc.2006.10.001_bib42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/A:1006629328178","article-title":"Molecular events of bacterial-induced maturation of dendritic cells","volume":"20","author":"Rescigno","year":"2000","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.urolonc.2006.10.001_bib43","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1182\/blood.V99.9.3427","article-title":"Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferon-gamma: A molecular basis for priming and synergism with bacterial lipopolysaccharide","volume":"99","author":"Bosisio","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.urolonc.2006.10.001_bib44","doi-asserted-by":"crossref","first-page":"38105","DOI":"10.1074\/jbc.R300028200","article-title":"Toll-like receptor signaling","volume":"278","author":"Akira","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.urolonc.2006.10.001_bib45","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/00008480-200306000-00009","article-title":"Toll-like receptor signaling in sepsis","volume":"15","author":"Lakhani","year":"2003","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.urolonc.2006.10.001_bib46","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.4049\/jimmunol.169.6.2823","article-title":"Cutting edge: Myeloid differentiation factor 88 deficiency improves resistance against sepsis caused by polymicrobial infection","volume":"169","author":"Weighardt","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.urolonc.2006.10.001_bib47","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nature736","article-title":"Severe impairment of interleukin-1 and Toll-like receptor signaling in mice lacking IRAK-4","volume":"416","author":"Suzuki","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2006.10.001_bib48","doi-asserted-by":"crossref","first-page":"13875","DOI":"10.1073\/pnas.95.23.13875","article-title":"Anti-CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin","volume":"95","author":"Schimke","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.urolonc.2006.10.001_bib49","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1084\/jem.20021340","article-title":"Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen","volume":"196","author":"Eisenbarth","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.urolonc.2006.10.001_bib50","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0008-6363(03)00348-1","article-title":"Toll-like receptors in cardiovascular diseases","volume":"60","author":"de Kleijn","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.urolonc.2006.10.001_bib51","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJMoa012673","article-title":"Toll-like receptor 4 polymorphisms and atherogenesis","volume":"347","author":"Kiechl","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2006.10.001_bib52","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1399-0039.2005.00454.x","article-title":"Toll-like receptor 3 gene polymorphisms in South African Blacks with type 1 diabetes","volume":"66","author":"Pirie","year":"2005","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.urolonc.2006.10.001_bib53","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.1128\/IAI.68.12.6883-6890.2000","article-title":"Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guerin: involvement of toll-like receptors","volume":"68","author":"Tsuji","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.urolonc.2006.10.001_bib54","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A Toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2006.10.001_bib55","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1158\/0008-5472.CAN-03-3280","article-title":"Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: Results from the Cancer Prostate in Sweden Study","volume":"64","author":"Zheng","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2006.10.001_bib56","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/jnci\/dji070","article-title":"Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk","volume":"977","author":"Sun","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2006.10.001_bib57","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1126\/science.282.5396.2085","article-title":"Defective LPS signaling in C3H\/HeJ and C57BL\/10ScCr mice: Mutations in Tlr4 gene","volume":"2825396","author":"Poltorak","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.urolonc.2006.10.001_bib58","first-page":"137","article-title":"CD14 dependent and independent signaling pathways in murine macrophages from normal and CD14 \u201cknockout\u201d (CD14KO) mice stimulated with LPS or taxol","volume":"397","author":"Vogel","year":"1998","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.urolonc.2006.10.001_bib59","doi-asserted-by":"crossref","first-page":"558","DOI":"10.4049\/jimmunol.164.2.558","article-title":"Cutting edge: Heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex","volume":"164","author":"Ohashi","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.urolonc.2006.10.001_bib60","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0167-4781(00)00289-X","article-title":"Identification of hTLR10: A novel human Toll-like receptor preferentially expressed in immune cells","volume":"1518","author":"Chuang","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.urolonc.2006.10.001_bib61","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4049\/jimmunol.169.1.10","article-title":"Cutting edge: Role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins","volume":"169","author":"Takeuchi","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.urolonc.2006.10.001_bib62","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.molimm.2003.10.006","article-title":"TIR domain-containing adaptors define the specificity of TLR signaling","volume":"40","author":"Yamamoto","year":"2004","journal-title":"Mol Immunol"},{"key":"10.1016\/j.urolonc.2006.10.001_bib63","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/intimm\/13.7.933","article-title":"Discrimination of bacterial lipoproteins by Toll-like receptor 6","volume":"13","author":"Takeuchi","year":"2001","journal-title":"Int Immunol"},{"key":"10.1016\/j.urolonc.2006.10.001_bib64","doi-asserted-by":"crossref","first-page":"13766","DOI":"10.1073\/pnas.250476497","article-title":"The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors","volume":"97","author":"Ozinsky","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.urolonc.2006.10.001_bib65","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4049\/jimmunol.166.1.15","article-title":"Cutting edge: Functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin","volume":"1661","author":"Hajjar","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.urolonc.2006.10.001_bib66","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1128\/CMR.16.4.637-646.2003","article-title":"Role of Toll-like receptors in pathogen recognition","volume":"16","author":"Janssens","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.urolonc.2006.10.001_bib67","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/1521-4141(200204)32:4<1182::AID-IMMU1182>3.0.CO;2-9","article-title":"Toll-like receptor 1 inhibits Toll-like receptor 4 signaling in endothelial cells","volume":"32","author":"Spitzer","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.urolonc.2006.10.001_bib68","first-page":"103","article-title":"Expression of a novel member of the TGF-beta superfamily, growth\/differentiation factor-15\/macrophage-inhibiting cytokine-1 (GDF-15\/MIC-1) in adult rat tissues","volume":"2971","author":"Bottner","year":"1999","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.urolonc.2006.10.001_bib69","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0167-4781(97)00122-X","article-title":"PLAB, a novel placental bone morphogenetic protein","volume":"1354","author":"Hromas","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.urolonc.2006.10.001_bib70","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ijc.1291","article-title":"Placental bone morphogenetic protein (PLAB) gene expression in normal, pre-malignant and malignant human prostate: Relation to tumor development and progression","volume":"931","author":"Thomas","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2006.10.001_bib71","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/sj.bjc.6600869","article-title":"Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues","volume":"88","author":"Nakamura","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2006.10.001_bib72","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1073\/pnas.0530278100","article-title":"Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum","volume":"100","author":"Welsh","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.urolonc.2006.10.001_bib73","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1086\/321281","article-title":"A genome screen of families with multiple cases of prostate cancer: Evidence of genetic heterogeneity","volume":"69","author":"Hsieh","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.urolonc.2006.10.001_bib74","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/pros.10303","article-title":"Genome-wide scan of Swedish families with hereditary prostate cancer: Suggestive evidence of linkage at 5q11.2 and 19p13.3","volume":"57","author":"Wiklund","year":"2003","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2006.10.001_bib75","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/jnci\/djh227","article-title":"H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer","volume":"96","author":"Lindmark","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2006.10.001_bib76","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/BF00201602","article-title":"Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosus","volume":"94","author":"Clay","year":"1994","journal-title":"Hum Genet"},{"key":"10.1016\/j.urolonc.2006.10.001_bib77","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF02185776","article-title":"Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus","volume":"97","author":"Blakemore","year":"1996","journal-title":"Hum Genet"},{"key":"10.1016\/j.urolonc.2006.10.001_bib78","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/35006081","article-title":"Interleukin-1 polymorphisms associated with increased risk of gastric cancer","volume":"404","author":"El Omar","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2006.10.001_bib79","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1053\/gast.2001.28000","article-title":"Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma","volume":"121","author":"Machado","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.urolonc.2006.10.001_bib80","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/sj.bjc.6602729","article-title":"Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk","volume":"93","author":"Lindmark","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2006.10.001_bib81","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0090-4295(00)00844-X","article-title":"Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions","volume":"56","author":"Hochreiter","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2006.10.001_bib82","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0090-4295(98)00390-2","article-title":"Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis\/chronic pelvic pain syndrome","volume":"52","author":"Alexander","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2006.10.001_bib83","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0022-5347(05)67497-6","article-title":"IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis","volume":"164","author":"Nadler","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2006.10.001_bib84","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.neo.7900124","article-title":"Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice","volume":"3","author":"Kim","year":"2001","journal-title":"Neoplasia"},{"key":"10.1016\/j.urolonc.2006.10.001_bib85","first-page":"3369","article-title":"Influence of cytokine gene polymorphisms on the development of prostate cancer","volume":"62","author":"McCarron","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2006.10.001_bib86","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.gene.6363733","article-title":"Cytokine gene polymorphism in human disease: On-line databases, supplement 1","volume":"2","author":"Bidwell","year":"2001","journal-title":"Genes Immun"},{"key":"10.1016\/j.urolonc.2006.10.001_bib87","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1136\/thorax.55.12.1023","article-title":"Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families","volume":"55","author":"Hull","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.urolonc.2006.10.001_bib88","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1681\/ASN.V131260","article-title":"Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection","volume":"13","author":"Shahbazi","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.urolonc.2006.10.001_bib89","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/S0022-5347(01)64775-X","article-title":"Vascular endothelial growth factor (VEGF) expression in human prostate cancer: In situ and in vitro expression of VEGF by human prostate cancer cells","volume":"157","author":"Ferrer","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2006.10.001_bib90","doi-asserted-by":"crossref","first-page":"8906","DOI":"10.1158\/0008-5472.CAN-04-1788","article-title":"Large-scale association study identifies ICAM gene region as breast and prostate cancer susceptibility locus","volume":"64","author":"Kammerer","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2006.10.001_bib91","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1210\/jc.2003-030131","article-title":"Intercellular adhesion molecule 1 gene polymorphisms in Graves\u2019 disease","volume":"88","author":"Kretowski","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.urolonc.2006.10.001_bib92","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/gut.52.1.75","article-title":"Association between K469E allele of intercellular adhesion molecule 1 gene and inflammatory bowel disease in a Japanese population","volume":"52","author":"Matsuzawa","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.urolonc.2006.10.001_bib93","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0198-8859(02)00825-X","article-title":"Intercellular adhesion molecule-1 K469E polymorphism: Study of association with multiple sclerosis","volume":"64","author":"Nejentsev","year":"2003","journal-title":"Hum Immunol"},{"key":"10.1016\/j.urolonc.2006.10.001_bib94","first-page":"31","article-title":"Expression of intercellular adhesion molecule-1 in invasive breast cancer reflects low growth potential, negative lymph node involvement, and good prognosis","volume":"4","author":"Ogawa","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2006.10.001_bib95","first-page":"2022","article-title":"Stimulation of beta1 integrin down-regulates ICAM-1 expression and ICAM-1-dependent adhesion of lung cancer cells through focal adhesion kinase","volume":"61","author":"Yasuda","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2006.10.001_bib96","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/ijc.10514","article-title":"ICAM-1 expression and the soluble ICAM-1 level for evaluating the metastatic potential of gastric cancer","volume":"100","author":"Maruo","year":"2002","journal-title":"Int J Cancer"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143906002328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143906002328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:53:42Z","timestamp":1761040422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143906002328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":96,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S1078143906002328"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2006.10.001","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic variability in inflammation pathways and prostate cancer risk","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2006.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}